CD4 and neoplasm: Our data showed a numerical, but not statistically significant decrease, in tumor CXCR3+ CD4+ and CD8+ T lymphocytes, whereas CCR4+ CD4+ and CD8+ T lymphocytes were present at equal frequencies in tumor and in unaffected tissue.